These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


407 related items for PubMed ID: 12452874

  • 1. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
    Naumann MK, Hamm H, Lowe NJ, Botox Hyperhidrosis Clinical Study Group.
    Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
    [Abstract] [Full Text] [Related]

  • 2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M, Lowe NJ, Kumar CR, Hamm H, Hyperhidrosis Clinical Investigators Group.
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
    Naumann M, Lowe NJ.
    BMJ; 2001 Sep 15; 323(7313):596-9. PubMed ID: 11557704
    [Abstract] [Full Text] [Related]

  • 4. Same-patient prospective comparison of Botox versus Dysport for the treatment of primary axillary hyperhidrosis and review of literature.
    Vergilis-Kalner IJ.
    J Drugs Dermatol; 2011 Sep 15; 10(9):1013-5. PubMed ID: 22052270
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
    Schnider P, Moraru E, Kittler H, Binder M, Kranz G, Voller B, Auff E.
    Br J Dermatol; 2001 Aug 15; 145(2):289-93. PubMed ID: 11531794
    [Abstract] [Full Text] [Related]

  • 11. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
    Odderson IR.
    Dermatol Surg; 2002 Jun 15; 28(6):480-3. PubMed ID: 12081675
    [Abstract] [Full Text] [Related]

  • 12. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
    Campanati A, Sandroni L, Gesuita R, Giuliano A, Giuliodori K, Marconi B, Ganzetti G, Offidani A.
    J Eur Acad Dermatol Venereol; 2011 Aug 15; 25(8):917-21. PubMed ID: 21054569
    [Abstract] [Full Text] [Related]

  • 13. Evidence-based medicine: botulinum toxin in focal hyperhidrosis.
    Naumann M.
    J Neurol; 2001 Apr 15; 248 Suppl 1():31-3. PubMed ID: 11357238
    [Abstract] [Full Text] [Related]

  • 14. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
    Mostafa TAH, Hamed AA, Mohammed BM, El Sheikh NA, Shama AAA.
    Pain Physician; 2019 Nov 15; 22(6):591-599. PubMed ID: 31775406
    [Abstract] [Full Text] [Related]

  • 15. A preliminary study of painless and effective transdermal botulinum toxin A delivery by jet nebulization for treatment of primary hyperhidrosis.
    Iannitti T, Palmieri B, Aspiro A, Di Cerbo A.
    Drug Des Devel Ther; 2014 Nov 15; 8():931-5. PubMed ID: 25075176
    [Abstract] [Full Text] [Related]

  • 16. Lower relapse rate of botulinum toxin A therapy for axillary hyperhidrosis by dose increase.
    Karamfilov T, Konrad H, Karte K, Wollina U.
    Arch Dermatol; 2000 Apr 15; 136(4):487-90. PubMed ID: 10768647
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.